Bausch Health Companies financials
$5.80+0.52%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.27B | $9.63B | $8.76B | $8.12B | $8.43B | $8.03B | $8.60B | $8.38B |
| Gross profit | $7.25B | $6.84B | $6.20B | $5.76B | $6.04B | $5.78B | $6.25B | $6.03B |
| Gross margin | 70.7% | 71.1% | 70.8% | 70.9% | 71.6% | 72.0% | 72.7% | 71.9% |
| Operating income | $1.96B | $1.79B | $991.0M | $454.0M | $450.0M | $676.0M | -$203.0M | -$2.39B |
| Net income | $157.0M | -$46.0M | -$592.0M | -$225.0M | -$948.0M | -$560.0M | -$1.79B | -$4.15B |
| Net margin | 1.5% | −0.5% | −6.8% | −2.8% | −11.2% | −7.0% | −20.8% | −49.5% |
| Diluted EPS | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 |
| EBITDA | $3.46B | $3.20B | $2.89B | $2.75B | $2.75B | $2.64B | $1.98B | $3.34B |
| Operating cash flow | $1.40B | $1.60B | $1.03B | -$728.0M | $1.43B | $1.11B | $1.50B | $1.50B |
| Free cash flow | $1.00B | $1.26B | $817.0M | -$946.0M | $1.16B | $809.0M | $1.23B | $1.34B |
| Diluted shares | 375.0M | 368.0M | 364.9M | 362.0M | 358.9M | 355.0M | 352.1M | 351.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.31B | $1.18B | $947.0M | $564.0M | $582.0M | $605.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $20.84B | $21.62B | $22.39B | $20.77B | $22.65B | $23.93B |
| Total assets | $26.37B | $26.52B | $27.35B | $25.69B | $29.20B | $31.20B |
| Total liabilities | $25.99B | $26.84B | $27.43B | $25.43B | $29.24B | $30.59B |
| Shareholders' equity | $377.0M | -$322.0M | -$82.0M | $260.0M | -$34.0M | $605.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology